News

August 12, 2019 - ForteBio, the Biologics Business Unit of Molecular Devices, announced today at Bioprocessing Summit in Boston, the release of the new High Precision Streptavidin 2.0 (SAX2) biosensor for the Octet® platform. Focused on meeting customers… Read More
San Jose, Calif. – July 30, 2019 – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System. The new FLIPR Penta system… Read More
BENGALURU, KA, India and SAN JOSE, Calif., May 20, 2019 /PRNewswire/ -- Jubilant Biosys, a wholly owned subsidiary of Jubilant Life Sciences, announced today that it has recently added advanced Pioneer FE system to their platform of drug discovery… Read More
San Jose, CA — Molecular Devices, a global leader in life science analytical technologies, today announced the appointment of Susan Murphy as the new President of Molecular Devices, replacing Greg Milosevich who has been appointed President of Beckman… Read More
Announcing the CloneSelect™ Single-Cell Printer™ Series. Eyewitness proof of monoclonality. SAN JOSE, Calif., May 14, 2019 /PRNewswire/ -- Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced an expansion in its… Read More
March 12, 2019 - ForteBio, the Biologics Business Unit of Molecular Devices, announced today the availability of a new assay kit for high throughput glycan screening at the BioProcess International (BPI) West 2019 conference. The Sialic Acid (GlyS) kit,… Read More

New features enable live cell imaging and 3D acquisition in an easy to use system to better address phenotypic imaging

Molecular Devices announced several new features including environmental control and z-stack acquisition for the ImageXpress® Pico system, highlighted at ASCB | EMBO 2018, December 8-12 in San Diego, California. Scientists can now monitor and run live… Read More
San Jose, California, November 1, 2018 – Molecular Devices announced today the launch of the new SoftMax® Pro 7.1 GxP Software with complete validation tools which achieves full FDA 21 CFR Part 11 compliance in GMP/GLP labs.  Built on its current,… Read More

Industry leading ForteBio brand repositioned to focus on delivering breakthroughs in early stage biologic drug development.

Molecular Devices LLC, a leader in protein and cell biology technologies, today announced a new, exciting brand for its recently created biologics solutions business unit. The business unit combines the industry leading ForteBio label-free technology… Read More
Molecular Devices featured in Innovations TV segment Jupiter, Fla., Aug 8, 2018—Innovations with Ed Begley, Jr. proudly announces a brand-new episode, schedule to broadcast live on August 11, 2018 at 5:00p ET via Fox Business. Check your local listings… Read More